Table 1. Clinical Characters.

Characters	Microarray				qPCR
	Chronic hepatitis	Liver cirrhosis	Hepatocellular carcinoma		Chronic hepatitis	Liver cirrhosis	Hepatocellular carcinoma
n	29	31	38		104	112	100
Age, y
Mean	42.24	48.84	54.26		38.14	47.36	55.87
Range	30–77	32–65	31–81		22–77	25–72	25–81
Gender
M	23	27	32		69	80	80
F	6	4	6		35	32	20
TNM stage
T
T1	–	–	15		–	–	44
T2	–	–	6		–	–	20
T3	–	–	2		–	–	5
T4	–	–	12		–	–	14
N
N1	–	–	33		–	–	79
N2	–	–	1		–	–	3
M
M0	–	–	33		–	–	79
M1	–	–	1		–	–	3
AFP >20	3	7	30		13	28	55
AFP ≤20	26	24	8		91	84	45
ALT (IU/L)
Mean	48.24 (n=29)	56.23 (n=31)	92 (n=38)		53.15 (n=78)	51.51 (n=94)	54.25 (n=55)
Range	11–304	12–254	9–766.2		11–304	12–274	9–129.2
AST (IU/L)
Mean	33.07 (n=29)	50.87 (n=31)	101.2 (n=38)		35.54 (n=78)	51.08 (n=94)	62.31 (n=56)
Range	13–129	18–171	14.2–596.9		13–129	17–275	16–399
Bilirubin (μmol/L)
Mean	16.42 (n=28)	21.07 (n=31)	42.49 (n=38)		16.69 (n=78)	34.98 (n=93)	34.92 (n=52)
Range	4.7–39	7.3–51.2	4.9–592.3		4.7–39.2	5–436.4	4.9–530.4
Creatinine (μmol/L)
Mean	80.27 (n=15)	76.1 (n=21)	NA		76.83 (n=40)	73.91 (n=56)	66.29 (n=50)
Range	63–104	55–103	NA		47–141	31–181	36–104.7
Albumin (g/L)
Mean	43.71 (n=28)	40.29 (n=31)	40.17 (n=38)		44.1 (n=76)	39.85 (n=92)	39.17 (n=54)
Range	37–50	27–51	23.3–79.8		36.9–51	26.8–51	24.2–64.2
Etiology
CHB	26	28	35 (27 with LC)		84	93	82 (66 with LC)
CHC	2	0	1 (1 with LC)		15	6	0
AIH	0	0	0		1	3	1 (1 with LC)
Alcohol	0	1	0		0	3	0
Cryptogenic	1	2	2		4	7	17 (7 with LC)

M, male; F, female; CHB, chronic hepatitis B positive; LC, liver cirrhosis; CHC, chronic hepatitis C positive; AIH, autoimmune hepatitis.